We are live on ! Find out more
MAM

Meeder Asset Management Portfolio holdings

AUM $1.96B
1-Year Est. Return 48.96%
This Fund
S&P 500
This Quarter Est. Return
+5.63%
1 Year Est. Return
+48.96%
3 Year Est. Return
+156.47%
5 Year Est. Return
+196.14%
10 Year Est. Return
+689.54%
AUM
$1.12B
AUM Growth
+$72.9M
Cap. Flow
+$27.7M
Cap. Flow %
2.48%
Top 10 Hldgs %
21.95%
Holding
1,815
New
825
Increased
295
Reduced
449
Closed
98

Top Buys

Rank Stock Value
1
EMB icon
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
+$30.3M
2
SHY icon
iShares 1-3 Year Treasury Bond ETF
SHY
+$29.8M
3
EFA icon
iShares MSCI EAFE ETF
EFA
+$28M
4
IWO icon
iShares Russell 2000 Growth ETF
IWO
+$21.6M
5
TLT icon
iShares 20+ Year Treasury Bond ETF
TLT
+$12.9M

Top Sells

Rank Stock Value
1
HYG icon
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
+$23.4M
2
IWN icon
iShares Russell 2000 Value ETF
IWN
+$21.1M
3
AGG icon
iShares Core US Aggregate Bond ETF
AGG
+$9.96M
4
IEF icon
iShares 7-10 Year Treasury Bond ETF
IEF
+$9.83M
5
JNK icon
State Street SPDR Bloomberg High Yield Bond ETF
JNK
+$9.52M

Sector Composition

Rank Sector Weight
1 Technology 14.56%
2 Financials 13.71%
3 Healthcare 9.32%
4 Industrials 8.97%
5 Consumer Discretionary 7.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WW
1101
DELISTED
WW International
WW
$5K ﹤0.01%
334
– –
XPRO icon
1102
Expro Ltd
XPRO
$1.91B
$5K ﹤0.01%
+78
New +$5.49K
VIVS
1103
VivoSim Labs
VIVS
$1.64M
$5K ﹤0.01%
7
-3
-30% -$2.38K
EIGR
1104
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$5K ﹤0.01%
16
-3
-16% -$1.03K
RPT
1105
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
$5K ﹤0.01%
+334
New +$5.17K
NXGN
1106
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
$5K ﹤0.01%
322
– –
ICPT
1107
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$5K ﹤0.01%
+46
New +$5.37K
MGI
1108
DELISTED
MoneyGram International, Inc. New
MGI
$5K ﹤0.01%
+281
New +$3.78K
CNCE
1109
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$5K ﹤0.01%
297
-1,205
-80% -$14.5K
GBT
1110
DELISTED
Global Blood Therapeutics, Inc.
GBT
$5K ﹤0.01%
146
-490
-77% -$12.3K
AMPE
1111
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$5K ﹤0.01%
21
-6
-22% -$1.61K
HMTV
1112
DELISTED
Hemisphere Media Group, Inc.
HMTV
$5K ﹤0.01%
434
– –
LUB
1113
DELISTED
Luby's Inc.
LUB
$5K ﹤0.01%
+1,472
New +$5.3K
COR
1114
DELISTED
Coresite Realty Corporation
COR
$5K ﹤0.01%
+61
New +$5.3K
SNR
1115
DELISTED
NEW SENIOR INVESTMENT GROUP INC.
SNR
$5K ﹤0.01%
+455
New +$4.62K
QTS
1116
DELISTED
QTS REALTY TRUST, INC.
QTS
$5K ﹤0.01%
+99
New +$4.96K
MYOK
1117
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$5K ﹤0.01%
+354
New +$4.54K
ADSW
1118
DELISTED
Advanced Disposal Services Inc
ADSW
$5K ﹤0.01%
+214
New +$4.79K
RST
1119
DELISTED
ROSETTA STONE INC
RST
$5K ﹤0.01%
503
-720
-59% -$6.06K
PGNX
1120
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$5K ﹤0.01%
477
-162
-25% -$1.62K
UBNK
1121
DELISTED
United Financial Bancorp, Inc.
UBNK
$5K ﹤0.01%
+277
New +$4.87K
ALDR
1122
DELISTED
Alder Biopharmaceuticals
ALDR
$5K ﹤0.01%
+250
New +$5.53K
INSY
1123
DELISTED
Insys Therapeutics, Inc.
INSY
$5K ﹤0.01%
484
-1,513
-76% -$16.1K
IDTI
1124
DELISTED
Integrated Device Technology I
IDTI
$5K ﹤0.01%
+223
New +$5.47K
KERX
1125
DELISTED
Keryx Biopharmaceuticals Inc
KERX
$5K ﹤0.01%
+847
New +$4.64K
43 44
45
46 47

Similar funds

NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
FC
Finepoint Capital Boston, Massachusetts $1.95B AUM 45.61% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BC
Blackhill Capital Morristown, New Jersey $1.94B AUM 18.09% 1-Year Est. Return
FFH
Fairfax Financial Holdings Toronto, Ontario, Canada $1.94B AUM 27.76% 1-Year Est. Return
OCM
Osterweis Capital Management San Francisco, California $1.94B AUM 20.77% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

Meeder Asset Management's Q1 2017 Portfolio in Review

As of Q1 2017, Meeder Asset Management held 1,815 positions worth $1.12B, up 7% from $1.04B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Meeder Asset Management's Q1 2017 filing shows 825 new, 295 increased, 449 reduced and 98 closed positions. Its largest new stake was iShares 20+ Year Treasury Bond ETF: 107,709 shares worth $13M. The largest sale was iShares iBoxx $ High Yield Corporate Bond ETF, an estimated $23.4M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Financials and Healthcare.

  • Meeder Asset Management's largest Q1 2017 buy was iShares 20+ Year Treasury Bond ETF: 107,709 shares worth $13M.
  • Meeder Asset Management added most to iShares JPMorgan USD Emerging Markets Bond ETF in Q1 2017, an estimated $30.3M increase.
  • Meeder Asset Management's biggest Q1 2017 reduction was iShares iBoxx $ High Yield Corporate Bond ETF, cutting an estimated $23.4M.
  • Meeder Asset Management fully exited St Jude Medical in Q1 2017, selling an estimated $5.37M.
  • Meeder Asset Management's ten largest holdings make up 22% of its $1.12B portfolio in Q1 2017.
  • Meeder Asset Management opened 825 new positions and closed 98 in Q1 2017.
  • Meeder Asset Management's portfolio value rose 7% quarter-over-quarter to $1.12B.

Based on Meeder Asset Management's 13F filing for Q1 2017, filed 12 May 2017.